跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BRIEKA CAPSULE 150MG - HSA Drug Approval Details
Approvals
/
HSA
/
BRIEKA CAPSULE 150MG
Approved
THERAPEUTIC
BRIEKA CAPSULE 150MG
BALKANPHARMA-DUPNITSA AD (BULGARIA)
🇸🇬 Health Sciences Authority
Approval Date
Jan 23, 2018
Approval ID
1f5b5df7df80ce96
Company
BALKANPHARMA-DUPNITSA AD (BULGARIA)
Type
Therapeutic
Approval Details
Approval Id
1f5b5df7df80ce96
Drug Name
BRIEKA CAPSULE 150MG
Product Name
BRIEKA CAPSULE 150MG
Approval Number
SIN15408P
Approval Date
2018-01-23
Registrant
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence Holder
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
CAPSULE
Route Of Administration
ORAL
Atc Code
N03AX16
Atc Item Name
xn 03 ax 16
Pharma Manufacturer Name
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Company Detail Path
/organization/teva-pharmaceutical-investments-singapore-pte-ltd
Active Ingredients
Pregabalin
150.00 mg
PREGABALIN
150 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 23, 2018
Approval ID
1f5b5df7df80ce96
Type
Therapeutic
Back to HSA Approvals